Evidence map›Paper›PMID 31766415›Full record

ArticleJournal of clinical medicine2019

Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation.

Sabrina Pagano, Alessandra Magenta, Marco D'Agostino, Francesco Martino, Francesco Barillà, Nathalie Satta, Miguel A Frias, Annalisa Ronca, François Mach, Baris Gencer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Sabrina PaganoDivision of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospital, 4 rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland.
Alessandra MagentaFondazione Luigi Maria Monti, Istituto Dermopatico dell' Immacolata-IRCCS, Experimental Immunology Laboratory, Via dei Monti di Creta 104, 00167 Rome, Italy.
Marco D'AgostinoFondazione Luigi Maria Monti, Istituto Dermopatico dell' Immacolata-IRCCS, Experimental Immunology Laboratory, Via dei Monti di Creta 104, 00167 Rome, Italy.
Francesco MartinoDepartment of Pediatrics, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
Francesco BarillàDepartment of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatrical Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy.
Nathalie SattaDivision of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospital, 4 rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland.
Miguel A FriasDivision of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospital, 4 rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland.
Annalisa RoncaDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
François MachDivision of Cardiology, Geneva University Hospital, 1205 Geneva, Switzerland.
Baris GencerDivision of Cardiology, Geneva University Hospital, 1205 Geneva, Switzerland.
Elda FavariDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
Nicolas VuilleumierDivision of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospital, 4 rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland.
University of Geneva · CHIstituto Dermopatico dell'Immacolata · ITSapienza University of Rome · ITUniversity Hospital of Geneva · CHUniversity of Parma · IT

Funding

Fondation Centre de Recherches Médicales Carlos et Elsie de Reuter 315112Fondation Leenaards 3698Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030-163335
6 · The paper itself

Abstract

aimsAnti-Apolipoprotein A-1 autoantibodies (anti-ApoA-1 IgG) promote atherogenesis via innate immune receptors, and may impair cellular cholesterol homeostasis (CH). We explored the presence of anti-ApoA-1 IgG in children (5-15 years old) with or without familial hypercholesterolemia (FH), analyzing their association with lipid profiles, and studied their in vitro effects on foam cell formation, gene regulation, and their functional impact on cholesterol passive diffusion (PD).

methodsAnti-ApoA-1 IgG and lipid profiles were measured on 29 FH and 25 healthy children. The impact of anti-ApoA-1 IgG on key CH regulators (SREBP2, HMGCR, LDL-R, ABCA1, and miR-33a) and foam cell formation detected by Oil Red O staining were assessed using human monocyte-derived macrophages. PD experiments were performed using a validated THP-1 macrophage model.

resultsPrevalence of high anti-ApoA-1 IgG levels (seropositivity) was about 38% in both study groups. FH children seropositive for anti-ApoA-1 IgG had significant lower total cholesterol LDL and miR-33a levels than those who were seronegative. On macrophages, anti-ApoA-1 IgG induced foam cell formation in a toll-like receptor (TLR) 2/4-dependent manner, accompanied by NF-kB- and AP1-dependent increases of SREBP-2, LDL-R, and HMGCR. Despite increased ABCA1 and decreased mature miR-33a expression, the increased ACAT activity decreased membrane free cholesterol, functionally culminating to PD inhibition.

conclusionsAnti-ApoA-1 IgG seropositivity is frequent in children, unrelated to FH, and paradoxically associated with a favorable lipid profile. In vitro, anti-ApoA-1 IgG induced foam cell formation through a complex interplay between innate immune receptors and key cholesterol homeostasis regulators, functionally impairing the PD cholesterol efflux capacity of macrophages.

Indexed as

anti-apolipoprotein A-1 IgGcholesterol homeostasisfamilial hypercholesterolemiafoam cellsmiR-33apassive diffusionTLR2/4

Identifiers

PMID31766415
PMCPMC6947407
OpenAlexW2991620666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.